Technical Analysis for NVO - Novo Nordisk A/S

Grade Last Price % Change Price Change
B 132.89 0.39% 0.52
NVO closed up 0.39 percent on Monday, March 18, 2024, on 74 percent of normal volume.
16 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.39%
Calm After Storm Range Contraction -1.26%
Gapped Up Strength -1.26%
Calm After Storm Range Contraction -0.45%
Upper Bollinger Band Walk Strength -0.45%
180 Bullish Setup Bullish Swing Setup -1.64%
Upper Bollinger Band Walk Strength -1.64%
Above Upper BB Strength -1.64%
Upper Bollinger Band Touch Strength -1.64%
Upper Bollinger Band Walk Strength 1.26%

   Recent Intraday Alerts

Alert Time
Up 1% about 16 hours ago
60 Minute Opening Range Breakout about 18 hours ago
10 DMA Support about 20 hours ago
10 DMA Resistance about 21 hours ago
Fell Below Previous Day's Low about 21 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Novo Nordisk A/S Description

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Diabetes Pharmaceutical Products Inflammation Insulin Obesity Endocrine System Hormones Peptide Hormones Growth Hormone Diabetes Care Glucagon Like Peptide 1 Growth Hormone Therapy Pharmaceuticals Segment Anti Diabetic Drugs Haemophilia Hormone Therapy Related Delivery Systems

Is NVO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 138.28
52 Week Low 46.77
Average Volume 5,170,104
200-Day Moving Average 98.03
50-Day Moving Average 118.25
20-Day Moving Average 127.38
10-Day Moving Average 131.81
Average True Range 3.35
RSI (14) 61.98
ADX 41.91
+DI 38.50
-DI 19.65
Chandelier Exit (Long, 3 ATRs) 128.22
Chandelier Exit (Short, 3 ATRs) 128.36
Upper Bollinger Bands 138.18
Lower Bollinger Band 116.58
Percent B (%b) 0.76
BandWidth 16.96
MACD Line 4.54
MACD Signal Line 4.43
MACD Histogram 0.1131
Fundamentals Value
Market Cap 592.17 Billion
Num Shares 4.46 Billion
EPS 2.69
Price-to-Earnings (P/E) Ratio 49.40
Price-to-Sales 2.32
Price-to-Book 35.06
PEG Ratio 4.52
Dividend 9.40
Dividend Yield 7.07%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 136.91
Resistance 3 (R3) 136.75 135.25 136.24
Resistance 2 (R2) 135.25 134.22 135.33 136.01
Resistance 1 (R1) 134.07 133.59 134.66 134.23 135.79
Pivot Point 132.57 132.57 132.86 132.65 132.57
Support 1 (S1) 131.39 131.55 131.98 131.55 129.99
Support 2 (S2) 129.89 130.91 129.97 129.77
Support 3 (S3) 128.71 129.89 129.54
Support 4 (S4) 128.87